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Abstract
Background: Gamete and embryo donors undergo genetic screening procedures in order to maximise the health
of donor-conceived offspring. In the era of genomic medicine, expanded genetic screening may be offered to
donors for the purpose of avoiding transmission of harmful genetic mutations. The objective of this study was to
explore the attitudes of donors and recipients toward the expanded genetic screening of donors.
Methods: Qualitative interview study with thematic analysis, undertaken in a tertiary fertility centre. Semi-structured
in-depth qualitative interviews were conducted with eleven recipients and nine donors from three different cohorts
(sperm, egg and embryo donors/recipients).
Results: Donors and recipients acknowledged the importance of genetic information and were comfortable with
the existing level of genetic screening of donors. Recipients recognised some potential benefits of expanded genetic
screening of donors; however both recipients and donors were apprehensive about extended genomic technologies,
with concerns about how this information would be used and the ethics of genetic selectivity.
Conclusion: Participants in donor programs support some level of genetic screening of donors, but are wary of
expanding genetic screening beyond current levels.
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Plain English summary
A relatively small proportion of pregnancies are achieved
with the assistance of sperm donors, egg donors or
embryo donors. In most assisted reproductive clinics,
donors or sperm, eggs or embryos undergo some genetic
screening procedures in order to maximise the health of
donor-conceived offspring. Recent advances in genetic
testing technologies mean that it is now possible to
perform more extensive genetic screening of donors
than previously was possible.
In this study we conducted in depth interviews with
sperm, egg and embryo donors, and with recipients of
donor sperm, eggs or embryos, to explore their attitudes
towards the collection and use of genetic information in
the donor process, and towards the possibility of con-
ducting more extensive genetic screening of donors. Do-
nors and recipients all acknowledged the importance of
genetic information and were comfortable with the exist-
ing level of genetic screening of donors. Recipients
recognised some potential benefits of performing more
extensive genetic screening of donors; however both re-
cipients and donors were apprehensive about extended
genomic technologies, with concerns about how this in-
formation would be used and the ethics of genetic se-
lectivity. The study concludes that participants in donor
programs support some level of genetic screening of do-
nors, but are wary of expanding genetic screening be-
yond current levels.* Correspondence: david.amor@mcri.edu.au
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Background
Individuals who donate gametes (eggs or sperm) and
couples who donate embryos undergo genetic screening
procedures that are designed to maximise the health and
welfare of donor conceived children [1]. Practices vary
between clinics, but typically include two main compo-
nents: medical and family history of the donor and gen-
etic screening tests. The medical and family history of
the donor is designed to exclude the presence of major
mendelian disorders, chromosome rearrangements and
multifactorial disorders that have a significant genetic
component [2, 3]. Genetic tests undertaken in donors
may include karyotyping and genetic screening for the
carrier status of specific conditions such as cystic fibro-
sis, spinal muscular atrophy, haemoglobinopathies, Tay--
Sachs disease and Fragile X syndrome [2, 4, 5].
Despite implementation of these practices, it is inevitable
that serious inherited conditions will, on occasion, occur in
donor-conceived children or in individuals who have been
donors in the past. Reporting of such instances has
prompted calls for more extensive genetic screening of
donors [6–8], and advances in genetic testing technology
have now provided the opportunity for more expanded
genetic screening of gamete and embryo donors [9–11].
To date, most attention has been directed towards ex-
panded carrier screening for autosomal recessive disorders
[2, 12, 13], although new genetic testing technologies could
potentially be used to screen for undiagnosed autosomal
dominant disorders and even for susceptibility to some
multifactorial diseases [14].
There is little information about the attitudes of gam-
ete and embryo donors and recipients towards donor
genetic screening. A recent on-line survey of women
who had used donor sperm found support for the imple-
mentation of more comprehensive genetic screening of
donors [15]; however there are also concerns amongst
health professionals about the effectiveness of expanded
genetic screening protocols and the need to treat donors
as ‘interested stakeholders, not merely as providers of
genetic material’ [2]. In this research we aimed to ex-
plore the experiences and attitudes of gamete and
embryo donors and recipients towards current donor
genetic screening practices and towards potential future
expanded donor genetic screening.
Methods
Study setting - Melbourne IVF donor program
This research was conducted in the setting of the donor
program of Melbourne IVF, a large IVF provider based in
Victoria, Australia. In Victoria, the donation of reproduct-
ive tissues must be altruistic, and it is illegal for donors to
profit from their donation. In addition, a donor-conceived
person is entitled to access identifying information about
their donor. The Melbourne IVF donor program provides
a service whereby people can donate, or be recipients of,
gametes (eggs or sperm) and embryos. Donated embryos
are from couples and individuals who have undergone IVF
treatment and have completed their families. Donor pro-
gram criteria stipulate that at the time of donation, sperm
donors must be aged between 25 and 46 years and egg do-
nors must be aged between 25 and 40 years. Embryos can
be donated if the egg donor was aged less than 42 years at
the time of embryo creation. All donors must be Australian
citizens. Recipients of donor sperm must be aged less than
46 years and recipients of donor eggs or embryos must be
aged less than 51 years.
At Melbourne IVF, donors complete a Genetic Health
Questionnaire that collects information about personal
and family history of conditions with a suspected genetic
contribution. In addition to the genetic health question-
naire, donors undergo genetic screening to identify genetic
abnormalities that could be transmitted to children that
are conceived with their gametes or embryos. Screening
comprises a standard karyotype (looking for structural
rearrangements) and testing for three common single
gene disorders: thalassemia, spinal muscular atrophy and
cystic fibrosis. Female donors are also tested for Fragile X
syndrome.
Participants
Two groups of participants were invited to participate in
this study.
Recipients comprised recipients of gametes (sperm or
eggs) and recipients of donor embryos who:
 had used received IVF treatment at Melbourne IVF
using donor gametes or embryos between 2012 and
2014
 were not currently pregnant or undergoing IVF
treatment
 had not used a genetically related person as a donor
 could speak English.
Demographic data about recipients, including whether
or not a child had been born as a result of the donation,
were not collected in order to preserve confidentiality.
Donors comprised donors of gametes (sperm or eggs)
and embryo donors who:
 had donated between 2012 and 2014
 had not donated to a genetic relative
 could speak English.
Demographic data about donors, including whether or
not a child had been born as a result of their donation,
were not collected in order to preserve confidentiality.
Eligible individuals were contacted by phone and asked if
they would like to receive information about the study; an
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invitation pack was sent to those who indicated inter-
est. If no response was received from participants
after two weeks, a reminder was sent. Once a consent
form was received by the study team, the participants
were contacted to arrange a convenient time to par-
ticipate in the study. The most recently seen patients
were contacted first and recruitment continued until
thematic saturation had been reached.
Methodology
A qualitative methodological approach was employed in
this research in order to enable exploration of the expe-
riences of gamete donors and recipients in relation to
genetic screening.
Interviews
A semi structured interview schedule was developed
to address the specific research aims for each group
(Table 1). It included an exploration of the back-
ground to being a donor or recipient, experiences of
the health questionnaires, perceptions of important
information transfer and participant attitudes to gen-
etic information and genetic testing. Open ended
questions were used to allow participants to take the
discussion in any direction while maintaining focus of
the topic under investigation. Interviews were con-
ducted either face to face or by phone during a six
month period in 2015. Interviews of donors were
conducted by author NS and interviews of recipients
were conducted by author AK. All interviews were
digitally recorded.
Analysis
Digital recordings were transcribed verbatim using
ExpressScribe Software (NCH Software, Inc., Greenwood
Village CO, USA). Transcripts were de-identified and
pseudonyms assigned. Transcripts were imported into
NVivo Software (QSR International PTY Ltd., Mel-
bourne, Australia) and analysed using thematic analysis.
This involved a rigorous process of coding to identify
differences and similarities in order to develop themes
from within data [16]. A constant comparative approach
was used - coding began immediately and continued
throughout recruitment so that themes identified early
in the process could be further explored with partici-
pants in later interviews [17]. The initial stages of coding
were performed by NS and AK. The coding and categor-
izing of data were confirmed through co-coding by SL
and AM.
Ethics committee approval
This study was approved by the Human Research Ethics
Committee of Melbourne IVF, Victoria, Australia, refer-
ence number 39/15-MIVF.
Table 1 Interview Schedule used for donors and recipients
Areas to address
Domain Donors Recipients
Introduction − Why the participant became a gamete
or embryo donor
− Why the participant(s) required a gamete
or embryo donor
Expectations about information − Expectations of donor program
− What information donors thought they
would provide to potential recipients
− Expectations of recipient program
− What information the recipients thought
would be provided about potential donors
Experience of program regarding genetic information
(obtained from the donor Genetic Health Questionnaire)
− Thoughts after seeing questionnaires
− Unexpected information required
− Donors experience with the
questionnaires
− How the donors thought the
information would be used by recipients
− Thoughts after seeing completed
questionnaires
− Unexpected information given
− More/less information than previously
thought
− How recipients used the donor information
Importance of genetic information − What information donors thought




− What information was the most important




− Did this remain consistent throughout the
recipient process
Attitudes towards genetic information − Thoughts on need for genetic
information about donor
− Options of further genetic screening
− Personal and family implications
− Thoughts on need for genetic information
about potential donors
− Options for further genetic screening
Any other information required − Any other information donors feel could
have been provided to recipients
− Any other information recipients feel could
have been provided about potential donors




Thirty gamete/embryo recipients were identified from
the MIVF database. Twenty-five gamete/embryo recipi-
ents were contacted by phone and 23 agreed to be sent
an information pack. Nine recipients returned the con-
sent forms and were interviewed, giving a participation
rate of 39%. The recipient participants included three
sperm recipients, three egg recipients and three embryo
recipients. Two recipients were interviewed with their
partner, resulting in a total of 11 participants.
Donors
Thirty gamete/embryo donors were identified from the
Melbourne IVF database. All were contacted and agreed
to be sent an information pack. Eleven donors returned
consent forms and nine were available to be interviewed,
giving a participant rate of 30%. The donor participants
comprised three sperm donors, three egg donors and
three (female) embryo donors. Participant demographics
are shown in Table 2.
Recipient themes
Recipient themes are summarised in Fig. 1 and fall into
two main categories.
A) Existing genetic information and screening
Recipients felt that donor genetic information was im-
portant and helpful information to receive during the
donor program.
“Oh yeah, definitely, if you didn’t know that then it is
this world wide of unknown of what might happen in
your child’s future it’s definitely something important
that you need to know that” -Cathy, sperm recipient.
An egg recipient explained that the genetic informa-
tion normalised the need to discuss the information with
their known egg donor.
“The donor program is wonderful because it
normalises that you need to look for that so it could
feel quite intrusive like you are willing to give me a gift
and now I’m going to give you the third degree and
what’s your health like”-Anne, egg recipient.
Sperm recipients explained that it helped in the selec-
tion of their donor.
“Yeah, it definitely impacted I think from what we saw
on the form, it sort of helped us narrow it down to
another couple of donors”-Leonie, sperm recipient.
While genetic information was important, for many
recipients it did not play as significant a role as non-
genetic information when selecting a donor.
“I guess whilst all the genetic information was kind of
necessary the other side [non genetic information] was
far more important”-Cassie, sperm recipient.
Recipients mentioned their hope that medical ad-
vances would mean that in the future many genetic con-
ditions would be treatable.
“I was reasonably comfortable to take that risk and I
think also 20 or 30 years down the track hopefully
something would have come up”-Jane, embryo recipient.
Recipients explained that if they or their partner had a
family history of a genetic condition, it wouldn’t stop
them from having a family.
“When you meet someone …you don’t sort of ask all
the genetic information”-Leonie, sperm recipient.
Four recipients used donors who had a significant gen-
etic or family history, and felt the information was help-
ful but did not influence their choice of donor.
Table 2 Demographics of participants
Participants (pseudonyms) Donation Relationship status
Recipients
Cathy Sperm Different sex
Leonie and Cassie Sperm Same sex
Katrina Sperm Different sex
Anne Egg Different sex
Charlotte Egg Different sex
Lucy Egg Different sex
Jane Embryo Single
Kate Embryo Different sex
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“There was a letter saying that there is an increased
chance that she could develop hearing loss, but we
went with it because we thought well you know these
days they do a lot with hearing”-Cathy, sperm
recipient.
Recipients acknowledged that no donor was likely to
be free of any genetic risk, and were satisfied with the
amount of donor genetic information they received.
“The chances of getting someone with a perfectly clean
medical history is just negligible we are all going to die
from something whether it be a stroke, cancer, heart
disease, so let’s face it, when you put it on paper and it
looks scary but that is the reality for all of us”-Jane,
embryo recipient.
“For me I was happy with the knowledge that I
had”-Anne, egg recipient.
The feeling of being reassured by the genetic screening
process was a common theme among recipients.
“I actually found that to be very, very, very
reassuring”-Cassie, sperm recipient.
Recipients mentioned that the genetic information
provided an awareness of the risks for their future
children.
“It reassured me because it meant that the medical
team had looked at it and reviewed it and had given
me their opinions and percentages so I could make an
informed decision”-Charlotte, egg recipient.
Embryo recipients expressed how they had not previ-
ously thought about genetic information but they were
glad they had received it.
“You know what was really good? Even though I
hadn't thought of those things, I’m glad the
questionnaire was there”-Lucy, egg recipient.
B) Future genetic screening
Recipients discussed future genetic testing technolo-
gies that might be used in the donor program and
expressed that more information would be better in
their situation.
Fig. 1 Attitudes of donors and recipients towards genetic information. Themes were identified from participant interviews
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“But yeah I certainly think the more information the
better”-Jane, embryo recipient.
However the risk for too much information was also
highlighted.
“You don’t want to have information overload I
think”-Lucy, egg recipient.
Recipients from all cohorts expressed their interest in
having the option of more genetic information and found
it difficult to determine if it would be wanted or not.
“It is a really hard one to know whether we would really
have wanted more information”-Kate, embryo recipient.
“So it’s not as important to me, but I think the option
should be there”-Charlotte, egg recipient.
Recipients stated that more genetic information could
benefit many aspects of the donor program. One was
the wellbeing of the donor-conceived child.
“If you had more information it would be positive not
only from the selection point of view but from a
management point of view in the future”-Jane, embryo
recipient.
Recipients went on to discuss potential adverse conse-
quences from the introduction of new genetic technolo-
gies into the donor program. Ethical concerns were raised
about choosing donors based on their genetic information,
which they interpreted as a form genetic selectivity, or the
creation of “designer” babies.
“It would have given me pause for thought just because
it kind of…it sounds very much like it’s starting to
create designer babies”-Charlotte, egg recipient.
Recipients also felt that natural conceptions did not
involve this amount of genetic investigation so ques-
tioned why donor conceived pregnancies should.
“You know it is what it is, you know, so it is the risk
you take even if you are having your own children you
don’t know what is going to come”-Kate, embryo
recipient.
Recipients also viewed extra donor genetic investiga-
tion as potentially unhelpful.
“I think that if we looked into it too much it might
stop me from wanting a child”-Katrina, sperm
recipient.
The potential of expanded genetic screening to cause
anxiety was recognised by recipients, particularly when
discussing the possibilities of knowing about uncertain
genetic risks.
“For me if it was uncertain I would rather not know…
and then it’s not in the back of your head and you
don’t worry about it”-Cathy, sperm recipient.
Egg and embryo recipients were concerned about the
impact that expanded genetic screening would have on
donor numbers, with the majority claiming that they
would much rather have more donors than more
information.
“I don’t think there is anything wrong with the
information we have now so if I had the choice of more
chance of a donor and less information or more
information and less chance of a donor I would
probably go with the information that I have now
which is the current information and an increased
number of donors”-Lucy, egg recipient.
Egg recipients were particularly concerned about the
donors’ wellbeing and thoughts on further screening.
“And then making a donor go through genetic
screening because then…say by the way you have
made the offer but I want you to go get screened”-
Charlotte, egg recipient.
Egg recipients also felt that further genetic screening
would be something they would find difficult to ask the
donors to undergo.
“I’m not genetically screening myself, why would I do
that to someone else?”-Charlotte, egg recipient.
Donor themes
Donor themes are summarised in Fig. 1 and fall into two
main categories.
A) Existing genetic information and screening
The donors understood how important their medical
and genetic information was for recipients and found
the experience of providing this information to be a
positive one. Donors mentioned the difficulty of having
to find out their own family history, especially as some
of the donors had not told their family members of their
choice to donate. There were many factors identified
within the genetic screening process and the providing
of genetic information and these are outlined below.
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Donors felt comfortable answering the medical ques-
tions. A few of the donors needed further testing due to
a genetic condition being identified in the family history.
These donors questioned the relevance of this process,
partly because the genetic condition was in a distant
family member.
“I was surprised that I then had to provide a lot more
information about that, when…it was in relation to a
family member and not in relation to me” -Euan,
sperm donor.
Donors described their difficulty providing family
history information. Donors had to ask other family
members to help provide genetic histories, and some
found the process very interesting, in terms of gathering
all the information together.
“I found it good and I found it hard and sometimes
you don’t take notice of what happens in your
grandparents or you know what I mean”-Paige, egg
donor.
While all donors had to find out more about their
family histories, many struggled to know what to write
down on the Genetic Health Questionnaire, and were
unsure if certain health conditions identified in their
families were genetic or not.
“And it makes you think about things you do hear,
whether they are genetic, and you feel, should I write
this down, or shouldn’t I…”-Naomi, embryo donor.
When asked about the importance of testing, there
was a mixed response. Donors did not always see the
relevance of genetic screening, but recognised that
screening was important, especially if it could prevent
the passing on of a serious genetic disease.
“Personally I don’t see the relevance in it”-Becky, egg
donor.
“Well, I don’t have an issue with it. It’s safer to
know if you have an issue and to not donate, than
to accidently pass on a genetic disease”-Charlotte,
egg donor.
Although donors did not consistently recognise the
importance of genetic screening tests, all were comfort-
able undergoing the tests. Donors mentioned their ap-
prehension about finding out the results of their tests,
even though they knew of no genetic condition in the
family. They felt this was a normal anxious response to
having a medical test.
“There is always that thing of ah discovering stuff you
don’t know about…that can be both good and bad at
the same time”-Anthony, sperm donor.
The donors spoke about the level of scrutiny involved
in genetic screening, and drew the comparison with nat-
ural conception: they noted that a couple conceiving
naturally would not need to undergo genetic screening.
Donors also expressed opinions about the ethics of gen-
etic screening and whether this type of screening was
creating a child that could be superior to a naturally
conceived child.
“I mean I felt like they were trying to create a
super human or something... It is a little off putting,
that children, that people are selecting their
children”-Euan, sperm donor.
B) Future genetic screening
Donors spoke about the future of genetic screening
within donor programs. The participants expressed con-
cerns about the ethics of expanded genetic screening in
a donor program and whether this might lead to genetic
selectivity. One participant compared this type of genetic
screening to the movie ‘Gattaca’. Participants raised the
concept of the relative roles of genetic and environmen-
tal factors in child health, and thought that environmen-
tal factors play a greater role than genetics in a child’s
development.
“If it was me and the child was in my house, I would
be providing the growing situation and buying the
books, so I can influence what that person says more
than their sperm donor”-Ethan, sperm donor.
The level of scrutiny in genetic screening lead many
participants to voice their thoughts about the ethics of
genetic selectivity and referred to children resulting as
“designer babies”. Participants felt that a high level of
screening would promote the idea of the perfect child,
and felt uncomfortable with the idea of selectivity, which
they associated with a higher level of screening.
“…and the scary thing is then we can choose…choose
what sort of babies we are going to have and that’s
scary to me”-Becky, egg donor.
“Um, it would have given me pause for thought just
because it kind of…it sounds very much like it’s
starting to create designer babies”-Charlotte, egg
donor.
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Most donors, if required to go through this level of
screening, would not want to know their results. The
participants felt that the knowledge gained from these
results would adversely affect their life and personal
choices, especially if a detrimental disease was discov-
ered. However, while the participants did not want to
know their result, they were happy for the results to be
given to recipients if it would help them choose a donor.
Participants spoke about specific genetic diseases that
have incomplete penetrance. These participants felt that
knowing such a result would give them a lifelong fear
and would leave them struggling to plan a future. How-
ever one participant also worried about the laboratory
scientists knowing her information and what that would
mean for her privacy.
“When you find out that your children have
predispositions to illnesses and maybe if you don’t
know it could be…I don’t know if it’s good to know that
much…”-Naomi, embryo donor.
“I don’t think I would want those results personally
but I don’t mind if other people have those results or
that it’s tested for”-Ethan, sperm donor.
“But, then the scientists are going to know this
information about me”-Becky, egg donor.
Participants questioned whether society was "crossing
a line" by trying to create perfect human beings. Morally
they felt this type of screening was wrong and would
create inequality, especially for those who were con-
ceived naturally. There was a general feeling that
technology has advanced very quickly but the science
is still lacking and more thought should be given as
to whether these testing procedures could do more
harm than good.
“There would be things that you would need to draw
the line somewhere, things that are controllable and
things that aren’t controllable, to not create a society
which is too bound by perfecting itself”-Charlotte, egg
donor.
Donors were also concerned that an increased level of
genetic screening would affect whether individuals
would choose to donate. These participants thought
they would still donate if expanded screening was
introduced; however many of these participants would
not want to know their own results. Participants
worried about the impact this level of screening
would have on their lives and thought that more
thought should be given into whether this level of
screening is ethical or beneficial.
“I think less people would [want to donate]. I mean…
um…we all have a little something in our closet that
we don’t want to share with others”-Becky, egg donor.
Discussion
This qualitative study explored attitudes towards the
genetic screening of gamete (sperm or egg) and embryo
donors, from the dual perspectives of the donors and
the recipients, providing valuable information that will
assist in the design and implementation of donor pro-
grams in the context of the availability of expanded gen-
etic screening. All donors and recipients had personal
experience of the donor screening process at Melbourne
IVF, which comprised a Genetic Health Questionnaire
and limited genetic testing.
In relation to the Genetic Health Questionnaire, all
donors and recipients understood the importance of the
information contained in the questionnaire. However
some donors had difficulty filling out the questionnaire
because they were uncertain about aspects of their fam-
ily history, and about whether or not certain medical
conditions in their family history were genetic in origin.
While the questionnaire is a cost effective way of gather-
ing family history information, our results suggest that
the process could lead to misinformation, and a face-to-
face interview may be more effective. Recipients appreci-
ated and valued the information provided by donors in
the Genetic Health Questionnaire, but also felt that
when selecting a donor, this information was less im-
portant than non-health related information, such as
physical attributes, values and beliefs, and character de-
scriptors. Most recipients did not feel that they would
reject a donor based on family medical history informa-
tion alone. Although previous studies have not addressed
attitudes towards genetic information, our results are
comparable to a previous Australian study which showed
that health information was ranked as the most important
type of donor information by sperm and egg recipients
and by egg donors; sperm donors ranked health informa-
tion as the second most important form of donor informa-
tion, behind donor physical characteristics [18].
Donors and recipients supported the existing level of
genetic testing in the donor program, which comprises
karyotype and carrier screening for thalassemia, spinal
muscular atrophy, cystic fibrosis and Fragile X syn-
drome. Some donors questioned the relevance of these
tests but nonetheless were happy to be tested. However
when asked about the opportunity for expanded genetic
testing of donors, donors and recipients had reservations
and questioned the desirability of expanded genetic
screening. A specific concern expressed by donors and
recipients alike was that choosing donors based on the
results of expanded genetic screening might represent
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an undesirable move towards genetic selectivity, which
they likened to having a "designer baby". In addition,
donors and recipients expressed concern that increased
genetic screening might deter donors from donating,
resulting in a decline in donor numbers.
Donors also expressed concern about the psycho-
logical impact of them receiving this additional genetic
information. Interestingly, some donors stated that
although they would consent to expanded genetic
screening being performed in them, they would not wish
to be informed of the results. In practice, IVF clinics are
unlikely to agree to such a request, as it would place
both the clinic and the recipient in the position of hold-
ing undisclosed genetic information that might be im-
portant for the health of the donor. Recipients were
concerned that expanded genetic screening of donors
might cause increased anxiety to recipients, as well as
increasing the financial cost of accessing the donor
program. Although many recipients recognised potential
benefits of having more genetic information about
donors, such as an opportunity to maximise the health
of their donor-conceived child, they were uncertain
whether they would actually want this information
themselves. In addition, participants highlighted the
important contribution of environmental factors to child
health, and did not view child health as being deter-
mined only by genetics.
No recipients were strongly in favour of receiving ex-
tended screening and genetic information about donors.
Although attitudes towards extended carrier screening
have not been studied in a donor population, reticence
about the extended carrier screening has previously been
observed amongst health professionals and patient
representatives, with particular concerns centring on the
ethical and psychological challenges of expanded carrier
screening [9, 19, 20].
Genetic information was viewed differently by recipi-
ents of donor sperm compared to recipients of donor
eggs/embryos. In particular, whilst genetic information
was viewed by recipients of donor sperm as a factor in
their selecting a sperm donor, recipients of donor eggs
or embryos mostly saw genetic information as some-
thing to be passed on to their offspring. This was partly
because recipients of donor eggs or embryos had less
opportunity to choose between alternative donors, and
because egg donors were known to their recipients. Egg
recipients in particular reported not having considered
the genetic history of the donor before they were
provided with the genetic health questionnaires.
Overall, this research has highlighted that while do-
nors and recipients are supportive of existing genetic
screening of gamete and embryo donors, they have res-
ervations about expanded genetic screening. This was
particularly prominent amongst donors, but was also an
issue for recipients who were concerned about the im-
pact of expanded genetic screening on the cost and
availability of accessing donors. These findings contrast
to those of Sawyer et al. [15] who found support
amongst recipients for expanded genetic screening of
donors and a willingness from recipients to pay extra for
this service. Notably, the study by Sawyer et al. was con-
ducted as an on line survey, with 85% of respondents
residing in the USA. Differences between the results of
the two studies may be due to differences in study meth-
odology, and between donor programs in USA and
Australia. In Australia, the perspectives of donors and
recipients are likely influenced by the fact that donation
of reproductive tissues must be altruistic, and it is illegal
for donors to profit from their donation. When inter-
preting this study, it is also important to note that the
number of donors and recipients in each category (egg/
sperm/embryo) is small and may not be representative
of the donor community as a whole. In addition, the
overall participation rate of 34% represents a potential
source of bias.
Conclusion
Participants in our donor program support some level of
genetic screening of donors, but have concerns about
expanding genetic screening beyond current levels. The
implementation of expanded genetic screening in donor
programs may do more harm than good.
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